Yuki Tsukada of Shiga International Patent Office says the rulings will ease enforcement of patent rights on network-related inventions and suggests legislative reform may be on the horizon ...
Identification and quantification of HER2/neu as a proto-oncogene has led to humoral or antibody-based passive immunotherapy, including the use of trastuzumab (Herceptin®). The invention discussed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback